Cook Biotech is dedicated to providing advanced tissue-repair products for improving patient outcomes globally.
Products are manufactured using proprietary extracellular matrix (ECM) technologies and manufacturing processes.
Through collaboration with partners and distributors, Cook Biotech products are available globally under several brand names, including Vim™, Biodesign® and OASIS®.
Applications for ECM technology continually evolve. Together with a global network of scientists, partners, and medical practitioners, we continue to identify medical needs most compatible with ECM technology and develop products to meet those needs.
Cook Biotech is located in West Lafayette, Indiana, USA, and is a sister company to Cook Medical of Bloomington, Indiana. Learn more about Cook Biotech at cookbiotech.com and cookbiotech.eu.
Kerecis is pioneering the use of fish skin and fatty acids in the globally expanding cellular therapy and infection control markets.
The Kerecis fatty-acid-rich intact fish skin protects the body’s tissues and enables it to regenerate tissues. The Kerecis sprayable fatty-acid topical and oral formulations protect the body from bacterial and viral infections.
Our products are being used to treat wounds, burns and other complex acute and chronic wounds including diabetic, venous, trauma, and surgical wounds. Thousands of patients of all incomes, cultures and races have benefited from treatment with Kerecis.
Our fish skin comes from wild Atlantic cod, caught from a sustainable fish stock in pristine Icelandic waters and processed using renewable energy.
MiMedx® is an industry leader in advanced wound care and a therapeutic biologics company developing and distributing human placental tissue allografts with patent-protected processes for multiple sectors of healthcare. The Company processes the human placental tissue utilizing its proprietary Purion® process methodology, among other processes, to produce allografts by employing aseptic processing techniques in addition to terminal sterilization. MiMedx has supplied over two million allografts, through both direct and consignment shipments.
The Spincare Wound Care System - Changing lives, not dressings
Nanomedic’s portable, handheld Spincare system is a fully personalized system, coupled with a disposable, single patient polymer-based sterile solution ampule enables faster and pain-reduced healing through real-time printing of a site-specific nanofibrous matrix directly onto a wound. Spincare utilizes proprietary Electrospun Healing Fiber (EHF™) technology to treat even the most severe and complicated wounds with a single application, eliminating the need for painful re-dressings. It solves both the short-term and long-term healing challenges.
ABIGO Medical AB is a Swedish pharmaceutical company that owns, develops, manufacturers and markets pharmaceutical products and medical devices.
The main medical device applications are advanced wound management (AWM), ear, nose and throat (ENT), and nutrition. The company was founded in 1989 and in May 2020, the hygiene and health company Essity, acquired 75% of the company. ABIGO Medical is thereby a key partner and a sub-supplier to Essity as ABIGO develops, manufacturers and markets products including, the company's own registered trademark, Sorbact®.
Infection control and the fight against antibiotic resistance are focus areas. Based on natural processes and physical interactions, Sorbact® removes bacteria, irreversibly binding them to its surface to reduce bioburden and support wound healing. By this mode of action, Sorbact® dressings may lower the use of antibiotics and provide a contribution in the management and prevention of wound infection and, resistance is not likely to occur from binding of microorganisms.
Essity is a leading global hygiene and health company dedicated to improving well-being through products and solutions. Essity’s Medical Solutions segment offers products in wound care, compression therapy and orthopedics.
With world-renowned brands, Essity is one of the global market leaders in a number of therapeutic areas. Leukoplast stands for fast and efficient fixation and treatment of surgical and minor wounds. Cutimed is the specialist for the management of chronic and complex wounds. JOBST provides a comprehensive range of product solutions for patients with venous conditions, lymphedema and lipedema.
Essity takes an important step forward, supporting medical specialists with integrated therapy solutions. These form the basis of a holistic approach to treat medical conditions such as venous leg ulcers, offering both compression garments and wound dressings, to support optimal wound healing.
Accel-Heal Technologies Limited is a UK-based company that was established to continue the development of unique electrical stimulation products designed to help transform clinical and health economic outcomes in patients with painful and hard-to-heal wounds.
Electrical stimulation is one of the most evidence-based technologies in wound management with five meta analysesand over 30 RCTs published today.
The challenge has always been how to incorporate what has been perceived as a complex therapy, into a simple to use format in frontline clinical practice. Accel‑Heal, as a pre-programmed, single-use, wearable and easy to use electrical stimulation device, has been developed to address this challenge.